Amygdalin epimers exert discrepant anti-pulmonary fibrosis activity via inhibiting TGF-β1/Smad2/3 pathway
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Amygdalin epimers exert discrepant anti-pulmonary fibrosis activity via inhibiting TGF-β1/Smad2/3 pathway
Authors
Keywords
-
Journal
PULMONARY PHARMACOLOGY & THERAPEUTICS
Volume 81, Issue -, Pages 102230
Publisher
Elsevier BV
Online
2023-06-25
DOI
10.1016/j.pupt.2023.102230
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fibroblast Senescence in Idiopathic Pulmonary Fibrosis
- (2020) Yifan Lin et al. Frontiers in Cell and Developmental Biology
- Inhibitory effects of alkaline extract from the pericarp of Citrus reticulata Blanco on collagen behavior in bleomycin-induced pulmonary fibrosis
- (2020) Ruo-Fei Li et al. JOURNAL OF ETHNOPHARMACOLOGY
- Cyanide and lactate levels in patients during chronic oral amygdalin intake followed by intravenous amygdalin administration
- (2019) Jens Mani et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Rebound metabolic acidosis following intentional amygdalin supplement overdose
- (2019) Rachel M. Shively et al. CLINICAL TOXICOLOGY
- Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium
- (2019) Yuan Yao et al. Stem Cell Research & Therapy
- An emerging role of neutrophils and NETosis in chronic inflammation and fibrosis in systemic lupus erythematosus (SLE) and ANCA-associated vasculitides (AAV): Implications for the pathogenesis and treatment
- (2019) Eleni Frangou et al. AUTOIMMUNITY REVIEWS
- Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
- (2019) Kevin R. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Editorial overview: Fibrosis
- (2019) Lee Borthwick et al. CURRENT OPINION IN PHARMACOLOGY
- Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
- (2019) Boris Hinz et al. Nature Reviews Rheumatology
- Knockdown of LOXL1 inhibits TGF-β1-induced proliferation and fibrogenesis of hepatic stellate cells by inhibition of Smad2/3 phosphorylation
- (2018) Li Ma et al. BIOMEDICINE & PHARMACOTHERAPY
- Amygdalin attenuates acute liver injury induced by D-galactosamine and lipopolysaccharide by regulating the NLRP3, NF-κB and Nrf2/NQO1 signalling pathways
- (2018) Fayin Tang et al. BIOMEDICINE & PHARMACOTHERAPY
- Idiopathic pulmonary fibrosis
- (2017) Luca Richeldi et al. LANCET
- Amygdalin blocks the in vitro adhesion and invasion of renal cell carcinoma cells by an integrin-dependent mechanism
- (2016) EVA JUENGEL et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Stereoselective metabolism of amygdalin-based study of detoxification of Semen Armeniacae Amarum in the Herba Ephedrae–Semen Armeniacae Amarum herb pair
- (2016) Shuai Song et al. JOURNAL OF ETHNOPHARMACOLOGY
- Activation of Slit2-Robo1 signaling promotes liver fibrosis
- (2015) Jianlan Chang et al. JOURNAL OF HEPATOLOGY
- Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling
- (2014) Anita Pathil et al. BRITISH JOURNAL OF PHARMACOLOGY
- EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling
- (2014) Sang-A Park et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Amygdalin inhibits renal fibrosis in chronic kidney disease
- (2013) JUNQI GUO et al. Molecular Medicine Reports
- Tissue Microenvironments Define and Get Reinforced by Macrophage Phenotypes in Homeostasis or during Inflammation, Repair and Fibrosis
- (2012) Marc Weidenbusch et al. Journal of Innate Immunity
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search